R and D capability and alliance formation in the pharmaceutical industry in India

Science and Public Policy

Volumn 27, Issue 2, 2000, Pages 109-121

  Sandhya, G D ^a   Visalakshi, S ^a  

^a National Institute of Science Technology and Development Studies India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; INDIA; PHARMACEUTICAL INDUSTRY;

BIOTECHNOLOGY; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT;

INDIA;

EID: 0034095631     PISSN: 03023427     EISSN: None     Source Type: Journal    
DOI: 10.3152/147154300781782101     Document Type: Article

References (30)

1. Daniele Archibugi and Jonathan Michie (1995). "The globalization of technology: a new taxonomy", Cambridge Journal of Economics. 19, pages 121-140.
2. Ashish Arora and Alfonso Gambardella (1990), "Complementarity and external linkages: the strategies of the large firms in biotechnology". The Journal of Industrial Economics, 38(4), pages 361-379.
3. P T Bolwijn and T Kumpe (1990), "Manufacturing in the 1990S: productive flexibility and innovation", Long Range Planning. 23, pages 44-57.
4. D J Bower (1993), "New product development in the pharmaceutical industry: pooling network resources", Journal of Product Innovation Management. 10, pages 367-375.
5. B Gomes-Casseres (1994), "Group versus group: how alliance networks compete", Harvard Business Review, 72 (July/August), pages 62-74.
6. M D Dibnerand N G Bruce (1987), "Greening of biotechnology, the growth of the US biotechnology industry", Trends in biotechnology, October.
7. Janet E Forrest and J C Martin (1992), "Strategic alliances between large and small research intensive organizations: experience in the BT industry", R&D Management, 22(1), pages 41-53.
8. P K Ghosh (1994), Personal communication.
9. J Hagedoorn (1996), "Trends and patterns in strategic technology partnering since the early seventies", Review of Industrial Organization, 11, pages 601-616.
10. C T Hill (1992), "New manufacturing paradigms". Technology Forecasting and Social Change. 41, pages 351-363.
11. J Howells, (1990), "The Intel-nationalization of R&D and the development of global research networks", Regional Studies, 24(6), pages 495-512.
12. D C Mowery, J E Oxley and B S Silverman (1996), "Strategic alliances and interfirm knowledge transfer", Strategic Management Journal, 17, pages 77-91.
13. Nature (1995), 9 February, page 523.
14. Walter W Powell (1996), "Inter-organizational collaborations in biotechnology industry", Journal of Institutional and Theoretical Economics, 152(1), pages 197-215.
15. Walter W Powell (1998), "Learning from collaboration: knowledge and networks in the BT and pharmaceutical industries", California Management Review, 40(3), Spring, pages 228-240.
16. Walter W Powell, Kenneth W Koput and Laurel Smith-Doerr (1996), "Interorganizational collaboration and the locus of innovation: networks of learning in biotechnology", Administrative Science Quarterly, 41, pages 116-145.
17. E Reis-Arndt (1987), "A quarter of a century of pharmaceutical research: new drug entities, 1961-85", Drugs made in Germany, 30(3), pages 105-112.
18. Ronald S Rogers (2000), "Pharmaceuticals under pressure", Chemical and Engineering News, 17 January, pages 21-32.
19. Roy Rothwell and Mark Dodgson (1991), "External linkages and innovation in small and medium-sized enterprises", R&D Management, 21(2), pages 125-137.
20. A M Sapienza (1989), "R&D collaboration as a global competitive tactic - biotechnology and the ethical pharmaceutical industry", R&D Management, 19(4), pages 3-16.
21. A M Sapienza (1993), "Assessing the R&D capability of the Japanese pharmaceutical industry", R&D Management, 23(1), pages 3-16.
22. Science (1994), 7 October, 266, page 66.
23. Scrip no 2215 (1997), 18 March, page 15.
24. Jacqueline Senker and Margaret Sharp (1997), "Organizational learning in cooperative alliances: some case studies in BT", Technology Analysis and Strategic Management. 9(1), pages 35-51.
25. D J Teece (1986), "Profiting from technological innovation: implications for integration, collaboration, licensing and public policy", Research Policy, 15, pages 285-305.
26. Francesco della Valle and Alfonso Gambardella (1993), "Biological revolution and strategies for innovation in pharmaceutical companies", R&D Management, 23(4), pages 287-302.
27. S Visalakshi, G D Sandhya and Dinesh Abrol (1995), "Assessment of R&D and production capabilities in pharmaceutical industry in India in the context of commercialisation of BT", Report no REP-156/95, NISTADS (CSIR), Delhi.
28. S Visalakshi and G D Sandhya (1997), "An analysis of biotechnology and non-biotechnology R&D capabilities in the Indian pharmaceutical industry", R&D Management, 27(2), pages 165-175.
29. A Webster and V Swain (1991), "The pharmaceutical industry: towards a new innovation environment", Technology Analysis and Strategic Management, 3(2), pages 127-142.
30. E Whittaker and D J Bower (1993), "A shift to external alliances for product development in the pharmaceutical industry", R&D Management, 24(3), pages 249-261.